Create new account

Register now and get additional benefits:
  • Personal prices
  • Delivery tracking
  • Pre-filled and quick checkout
  • Order history and fast re-ordering
  • Exact product stock status
Cart

Your cart is empty, just add some products

This is a fantastic opportunity to fill the cart with something really special!

Estimated shipping

€0.00

Total: €0.00

image/svg+xml Log in / Register
Log in or register
Log in Create account
Register now and get additional benefits:
  • Personal prices
  • Delivery tracking
  • Pre-filled and quick checkout
  • Order history and fast re-ordering
  • Exact product stock status
1-placeholder

SKU 119244

Staphylococcus aureus - Xen40 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the parental strain UAMS-1. Staph. aureus-Xen40 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.

Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS® imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research.

Revvity's bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers.

· Engineered Bacterium: Staphylococcus aureus - Xen40

· Parental Strain: UAMS-1

· In Vitro/Ex Vivo: Growth profiles, Catheter model

· In Vivo: Biofilm

Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro:

· Rapid and readily amenable to high throughput screening, e.g., 96 or 384-well format

· Sensitivity - subtle changes in cellular viability are rapidly detected

· Inexpensive - no additional substrates needed for bacterial assays

Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo:

· Rapid identification of lead drug candidates

· Real-time efficacy data

· May help to decrease drug failure by allowing disease relapse to be monitored in the same animal

For laboratory use only. This product is intended for animal research only and not for use in humans.

Specifications

Specifications

Documents

In-vivo-imaging-reagents-brochure.pdf

Brochure

EN | 3.1 MB

Download

Recently viewed

Company

Nova Natura UAB

Kaštonų g. 56, Giraitės k, LT-54310,
Kaunas, Lithuania

nova@novabio.lt
Phone: +370 (620) 70159

Reg No 305063819

Nova Natura OÜ

Valukoja 8, 11415,
Tallinn, Estonia

nova@novabio.ee
Phone: +372 5656 0050

Reg No 14758203

Let’s stay in touch

Join our newsletter!
ISO9001 1 e1593687280362